Extracorporeal membrane oxygenation for adults with respiratory failure secondary to cardiorespiratory disease: evolving indications and clinical practice
File(s)
Published version
Author(s)
Ocean, Nicola Mortimer
Patel, Brijesh
Garfield, Benjamin
Type
Journal Article
Abstract
Extracorporeal membrane oxygenation (ECMO) can support patients with severe cardiorespiratory failure presenting with hypoxia who would otherwise have not survived. Patient selection for ECMO is challenging and relies on the integration of physiological variables with an assessment of reversibility of the underlying condition or suitability for transplantation. In this review, we focus on patients with cardiorespiratory disease who may present with severe hypoxia. We will discuss the indications and contraindications for ECMO; the evidence for ECMO, which is limited to a small number of clinical trials and registry data; the complications of ECMO; expanding technologies and indications; the development of a multidisciplinary ECMO network; and future research. The aim is to increase knowledge of this important area for respiratory physicians.
Date Issued
2025-01-01
Date Acceptance
2024-11-18
Citation
Breathe, 2025, 21 (1)
ISSN
1810-6838
Publisher
European Respiratory Society
Journal / Book Title
Breathe
Volume
21
Issue
1
Copyright Statement
©ERS 2025 Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/39845438
PII: EDU-0119-2024
Subjects
COHORT
COVID-19
DISTRESS-SYNDROME
ECMO
HYBRID
Life Sciences & Biomedicine
LUNG-DISEASE
OUTCOMES
PREDICTING SURVIVAL
Respiratory System
Science & Technology
SHOCK
SUPPORT
Publication Status
Published
Coverage Spatial
England
Article Number
240119
Date Publish Online
2025-01-21